Literature DB >> 23505574

A young woman with liver cancer.

Celina S Ang1, Richard K Do, Ali Shamseddine, Eileen M O'Reilly, Ali Haydar, Ashwaq Al-Olayan, Walid Faraj, Fouad Boulos, Mohamed Naghy, Dorothy Makanjoula, Hassan Farran, Hassan Sibai, David Wehbe, David P Kelsen, Ghassan K Abou-Alfa.   

Abstract

Entities:  

Year:  2013        PMID： 23505574      PMCID： PMC3597934     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  33 in total

1.  Fibrolamellar hepatocellular carcinoma with alpha-one antitrypsin liver disease.

Authors:  Muneera Mohammed Al Bugami; Karim Louis Chaker Farahat; Hamad Ibrahim Al-Ashgar; Bo Hainau
Journal:  Saudi J Gastroenterol       Date:  2004-05       Impact factor: 2.485

2.  Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver.

Authors:  J J McCloskey; E L Germain-Lee; J A Perman; L P Plotnick; A H Janoski
Journal:  Pediatrics       Date:  1988-09       Impact factor: 7.124

Review 3.  Fibrolamellar hepatocellular carcinoma in children and adolescents.

Authors:  Howard M Katzenstein; Mark D Krailo; Marcio H Malogolowkin; Jorge A Ortega; Wenchun Qu; Edwin C Douglass; James H Feusner; Marleta Reynolds; John J Quinn; Kurt Newman; Milton J Finegold; Joel E Haas; Martha G Sensel; Robert P Castleberry; Laura C Bowman
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

4.  Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma.

Authors:  Wei Li; Dongfeng Tan; Maryam J Zenali; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2009-01-01

5.  Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.

Authors:  Stephen C Ward; Jiaoti Huang; Satish K Tickoo; Swan N Thung; Marc Ladanyi; David S Klimstra
Journal:  Mod Pathol       Date:  2010-05-21       Impact factor: 7.842

Review 6.  Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome.

Authors:  N P Nguyen; T L Borok; J Welsh; V Vinh-Hung
Journal:  Thorax       Date:  2009-02       Impact factor: 9.139

7.  Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy.

Authors:  V Maniaci; B R Davidson; K Rolles; A P Dhillon; A Hackshaw; R H Begent; T Meyer
Journal:  Eur J Surg Oncol       Date:  2009-01-13       Impact factor: 4.424

8.  Aggressive surgical management of fibrolamellar hepatocellular carcinoma.

Authors:  A W Hemming; B Langer; P Sheiner; P D Greig; B R Taylor
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

9.  Fibrolamellar hepatocellular carcinoma in pregnancy.

Authors:  M W Louie-Johnsun; P M Hewitt; D S Perera; D L Morris
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

10.  Neurotensin secretion by fibrolamellar carcinoma of the liver.

Authors:  N A Collier; K Weinbren; S R Bloom; Y C Lee; H J Hodgson; L H Blumgart
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321
View more
  1 in total

Review 1.  Liver diseases in pregnancy: diseases not unique to pregnancy.

Authors:  Ashraf A Almashhrawi; Khulood T Ahmed; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.